By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Gilead Sciences, Inc. 

333 Lakeside Drive

Foster City  California  94404  U.S.A.
Phone: 800-GILEAD-5 or 650-574-3000 Fax: 650-522-5800


SEARCH JOBS


Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need.The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.


Key Statistics


Email:
Ownership: Public

Web Site: Gilead Sciences, Inc.
Employees: 4,000
Symbol: GILD
 



Industry
Biotechnology






Company News
Only 60 Percent Of 60,000 Patients Will Get Gilead Sciences, Inc. (GILD)'s Solvadi In New York 9/19/2014 6:21:22 AM
Analyst: Gilead Sciences, Inc. (GILD) Still A Buy After Cancer Drug Fail 9/17/2014 5:49:21 PM
Hetero Enters License Agreement With Gilead Sciences, Inc. (GILD), U.S.A. To Produce Generic Sofosbuvir For Treatment Of Chronic Hepatitis C 9/17/2014 9:41:26 AM
Gilead Sciences, Inc. (GILD)'s Experimental Drug Simtuzumab Fails Mid-Stage Study 9/17/2014 6:00:11 AM
Mylan Inc. (MYL) Signs Agreement With Gilead Sciences, Inc. (GILD) To Accelerate Access To Hepatitis C Treatments, SovaldiĀ® (Sofosbuvir) And Single Tablet Regimen Of Ledipasvir/Sofosbuvir, in Developing Countries 9/15/2014 8:39:58 AM
Retrophin, Inc. (RTRX), Gilead Sciences, Inc. (GILD), And Our Healthcare Values 9/15/2014 6:47:12 AM
Gilead Sciences, Inc. (GILD) Says Indian Firms May Sell Generics of Hep C Drug Sovaldi 9/15/2014 6:05:24 AM
Gilead Sciences, Inc. (GILD) Release: First-Line Combination Of Ambrisentan And Tadalafil Reduces Risk Of Clinical Failure Compared To Monotherapy In Pulmonary Arterial Hypertension Outcomes Study 9/8/2014 10:52:13 AM
Gilead Sciences, Inc. (GILD) Close To Inking Deal That Would Bring Low-Cost Versions Of $84,000 Solvadi Drug To Poor Countries 9/5/2014 6:37:43 AM
Gilead Sciences, Inc. (GILD) To Present At Two Upcoming Investor Conferences In September 9/4/2014 12:38:18 PM
12345678910...
//-->